Tags
Results for: Fralin Biomedical--Cancer Research Group
-
Article ItemScientists uncover immune cells that help prostate cancer resist treatment and a way to stop them , article
Scientists at the Fralin Biomedical Research Institute identified a subtype of immune cells that helps advanced prostate cancer evade the body’s defenses, suggesting a new approach for treatment.
Date: Jul 10, 2025 - -
Article Item‘Every time we wait, we lose someone who might have made it’ , article
For every careful step forward in cancer research, there is a patient waiting — a family holding its breath in the middle of the night. That reality was clear at the Fralin Biomedical Research Institute’s Cancer Research Symposium.
Date: Jun 27, 2025 - -
Article ItemLymph node on a chip: New immune system model developed to enhance precision medicine research , article
The Fralin Biomedical Research Institute at VTC’s Munson lab completed one element of an engineered tissue model that could advance medical and drug testing and provide a new tool for precision medicine.
Date: Jun 18, 2025 - -
Article ItemNew study aims to improve treatment for pediatric brain cancer , article
With grant support from The Children’s Cancer Foundation Inc., a nonprofit that serves the Baltimore-Washington region, Fralin Biomedical Research Institute scientists are focused on ending an glioblastoma.
Date: Jun 09, 2025 - -
Article ItemAI-backed saliva test shows promise for flagging chemotherapy risk, early results indicate , article
Fralin Biomedical Research Institute at VTC scientists developed a saliva-based artificial intelligence screening method that could flag patients at risk for dangerous side effects from a widely used chemotherapy drug.
Date: Apr 22, 2025 - -
Article ItemFinding community and focus in interdisciplinary cancer research , article
Doctoral student Blanka Bordas had not planned to work in Washington, D.C., as she earned her degree, but opted to do so for the chance to work with an outstanding mentor on cancer research
Date: Apr 11, 2025 - -
Article Item'Pocket Science' podcast: Why don't I slosh when I walk? , article
Human beings are mostly water, and about a fifth of that water is interstitial fluid, flowing in the spaces between our cells. Jenny Munson tells us how understanding that fluid flow can be harnessed to better treat cancer, Alzheimer's and other diseases.
Date: Feb 26, 2025 - -
Article ItemChildren’s National Hospital, Virginia Tech expand research partnership to advance pediatric health , article
The partnership brings together Children’s National, ranked among the nation’s top pediatric hospitals by U.S. News & World Report, and Virginia Tech, a leading academic research institution.
Date: Feb 04, 2025 - -
Article ItemVirginia Tech award supports innovation in brain cancer treatment , article
Cairina Inc. co-founder Caleb Stine received a Presidential Postdoctoral Fellowship Award that puts the Fralin Biomedical Research Institute spinoff a step closer to making its research available to surgeons and oncologists.
Date: Sep 25, 2024 - -
Article ItemVirginia Tech, Children’s National Hospital, and industry experts explore the impact of AI on health care , article
While exploring the potential of artificial intelligence, old fashioned networking and human relationships held the floor.
Date: Sep 24, 2024 - -
Article ItemScientist awarded National Institutes of Health grant to examine cancer-related enzyme , article
Kathleen Mulvaney, assistant professor with the Fralin Biomedical Research Institute’s Cancer Research Center — D.C., will investigate the basic biology of PRMT5, an enzyme that can be found in 15 percent of human cancers.
Date: Sep 10, 2024 - -
Article ItemFederal leaders take center stage at Engineering Cancer Solutions mini-symposium , article
Three federal leaders – one each from the White House, the National Cancer Institute, and the Food and Drug Administration – mixed with Virginia Tech students, early career researchers, and leadership at the Fralin Biomedical Research Institute Cancer Research Center in Washington, D.C.
Date: Jul 12, 2024 - -
Article ItemDirector named for Fralin Biomedical Research Institute at VTC Cancer Research Center , article
An accomplished biomedical engineer who studies the biophysical setting of brain cancer has been named director of the Fralin Biomedical Research Institute at VTC’s Cancer Research Center in Roanoke
Date: Jul 10, 2024 - -
Article ItemFocused Ultrasound Foundation names Virginia Tech as a Center of Excellence , article
Virginia Tech becomes the sixth Focused Ultrasound Center of Excellence in the United States and one of only 12 in the world.
Date: Jun 04, 2024 - -
Article ItemResearchers reveal promising treatment target for resistant brain cancer , article
For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is a big problem. But now, Virginia Tech researchers with the Fralin Biomedical Research Institute at VTC may have moved a step closer to a solution.
Date: May 17, 2024 - -
Article ItemTesting for residual cancer cells before blood cell transplant therapy is important and practical, new study finds , article
Patients in remission after battling blood cancer are likely to have better outcomes if no trace of the cancer is detectable before the patients receive donor blood cells. The finding in JAMA Oncology emphasizes the importance of testing for lingering cancer cells in the body after people receive apparently successful chemotherapy treatment.
Date: May 02, 2024 - -
Article ItemVirginia Tech professor to be inducted into prestigious American Society for Clinical Investigation , article
Christopher Hourigan, director of the Cancer Research Center – D.C., has been inducted into the American Society for Clinical Investigation, a historic membership for a faculty member of Virginia Tech.
Date: Apr 04, 2024 - -
Article ItemEminent cancer physician-scientist joins Virginia Tech to lead research in Washington, D.C. , article
A National Institutes of Health senior investigator who studies and treats blood cancer, Christopher Hourigan is joining Virginia Tech to lead cancer research at the Fralin Biomedical Research Institute in Washington, D.C.
Date: Apr 01, 2024 - -
Article ItemJennifer Munson to be inducted into American Institute for Medical and Biological Engineering College of Fellows , article
Munson, a biomedical engineer and associate professor of the Fralin Biomedical Research Institute at VTC, joins a group of the nation’s top biological and medical engineers.
Date: Mar 20, 2024 - -
Article ItemData visualization aids Virginia Tech cancer researcher’s quest for better brain tumor treatment , article
Jennifer Munson, associate professor at the Fralin Biomedical Research Institute at VTC, shared her data on fluid flow in brain tumors with Virginia Tech’s Visionarium, which created 3D visualizations that allow new insights by Munson and her team.
Date: Feb 09, 2024 -
Page 1 of 2 | 30 Results